271 related articles for article (PubMed ID: 32032927)
1. Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients.
Bilchick KC; Wang Y; Curtis JP; Cheng A; Dharmarajan K; Shadman R; Dardas TF; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; O'Connor C; Levy WC
Am Heart J; 2020 Apr; 222():93-104. PubMed ID: 32032927
[TBL] [Abstract][Full Text] [Related]
2. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
Bilchick KC; Wang Y; Cheng A; Curtis JP; Dharmarajan K; Stukenborg GJ; Shadman R; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; Swedberg K; O'Conner C; Levy WC
J Am Coll Cardiol; 2017 May; 69(21):2606-2618. PubMed ID: 28545633
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
4. Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
Levy WC; Li Y; Reed SD; Zile MR; Shadman R; Dardas T; Whellan DJ; Schulman KA; Ellis SJ; Neilson M; O'Connor CM;
JACC Clin Electrophysiol; 2017 Mar; 3(3):291-298. PubMed ID: 28553663
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
7. CMR DENSE and the Seattle Heart Failure Model Inform Survival and Arrhythmia Risk After CRT.
Bilchick KC; Auger DA; Abdishektaei M; Mathew R; Sohn MW; Cai X; Sun C; Narayan A; Malhotra R; Darby A; Mangrum JM; Mehta N; Ferguson J; Mazimba S; Mason PK; Kramer CM; Levy WC; Epstein FH
JACC Cardiovasc Imaging; 2020 Apr; 13(4):924-936. PubMed ID: 31864974
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Multivariate Risk Estimation Models to Predict Prognosis in Patients With Implantable Cardioverter Defibrillators With or Without Cardiac Resynchronization Therapy.
Akoudad S; Dabiri Abkenari L; Schaer BA; Sticherling C; Levy WC; Jordaens L; Theuns DA
Am J Cardiol; 2017 May; 119(9):1414-1420. PubMed ID: 28267958
[TBL] [Abstract][Full Text] [Related]
9. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
[TBL] [Abstract][Full Text] [Related]
10. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.
Kristensen SL; Levy WC; Shadman R; Nielsen JC; Haarbo J; Videbæk L; Bruun NE; Eiskjær H; Wiggers H; Brandes A; Thøgersen AM; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Signorovitch J; Køber L; Thune JJ
JACC Heart Fail; 2019 Aug; 7(8):717-724. PubMed ID: 31302052
[TBL] [Abstract][Full Text] [Related]
11. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
14. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
[TBL] [Abstract][Full Text] [Related]
15. Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes.
Bilchick KC; Wang Y; Curtis JP; Shadman R; Dardas TF; Anand I; Lund LH; Dahlström U; Sartipy U; Levy WC
J Am Heart Assoc; 2022 Jul; 11(13):e023743. PubMed ID: 35766293
[TBL] [Abstract][Full Text] [Related]
16. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
Barra S; Providência R; Duehmke R; Boveda S; Marijon E; Reitan C; Borgquist R; Klug D; Defaye P; Sadoul N; Deharo JC; Sadien I; Patel K; Looi KL; Begley D; Chow AW; Le Heuzey JY; Agarwal S;
Heart; 2017 May; 103(10):753-760. PubMed ID: 28104669
[TBL] [Abstract][Full Text] [Related]
18. The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.
Ching CK; Hsieh YC; Liu YB; Rodriguez DA; Kim YH; Joung B; Singh B; Huang D; Hussin A; Chasnoits AR; O'Brien JE; Cerkvenik J; Lexcen D; Van Dorn B; Zhang S
J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2285-2294. PubMed ID: 34216069
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting.
Laish-Farkash A; Bruoha S; Katz A; Goldenberg I; Suleiman M; Michowitz Y; Shlomo N; Einhorn-Cohen M; Khalameizer V
Europace; 2017 Aug; 19(8):1357-1363. PubMed ID: 27733457
[TBL] [Abstract][Full Text] [Related]
20. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
